|

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

RECRUITINGSponsored by Beth Israel Deaconess Medical Center
Actively Recruiting
SponsorBeth Israel Deaconess Medical Center
Started2019-06-20
Est. completion2026-06-20
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04603196

Summary

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Written consent
* Over age 18
* Confirmed diagnosis of multiple sclerosis

Exclusion Criteria:

* cannot provide informed consent

Conditions2

Multiple SclerosisObstructive Sleep Apnea

Locations1 site

Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
Jacob sloane6176673726jsloane@bidmc.harvard.edu

Browse More Trials

Multiple Sclerosis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.